Fr. 174.00

Cell Therapy for Perinatal Brain Injury

English · Hardback

Shipping usually within 6 to 7 weeks

Description

Read more

This book provides a wealth of insights, advances and new perspectives on cell therapy for different types of neonatal ischemic disease, such as Hypoxic-Ischemic Encephalopathy (HIE), Periventricular Leukomalacia (PVL) and neonatal infarction.
These diseases pose serious challenges for neonatologists and neurologists, because the severe sequelae lead to decreasing QOL for patients and their families. Accordingly, new treatments for neonatal ischemic diseases are needed all over the world.
The book develops new effective therapies combined with hypothermia therapy, an established treatment for HIE. After reviewing past approaches, it presents cutting-edge topics in cell therapy, one of the most promising candidates for treating neonatal ischemic disease. Cell Therapy for Neonatal Ischemic Disease will offer readers a better understanding of the current state of the art in this field from bench to bedside, and inspire researchers and physicians to furtherexplore this evolving therapy.

List of contents

1. Clinical trial of autologous cord blood cell therapy for neonatal hypoxic-ischemic encephalopathy (HIE).- 2. New strategy of clinical studies for premature babies with ischemic brain damage .- 3. Pathophysiology and pathology of neonatal hypoxic-ischemic encephalopathy.- 4. Neural stem/progenitor cells for perinatal brain injury.- 5. Hematopoietic stem cells for perinatal brain injury.- 6. Umbilical cord-derived mesenchymal stromal cells for perinatal brain injury.- 7. Other tissues-derived mesenchymal stem cells for perinatal brain injury.- 8. CD34+ cell in cord blood and neonates.- 9. The History of Hypothermia therapy for perinatal ischemic brain injury.- 10. Clinical Procedure of Cell Therapy (Cord blood collection).- 11. Clinical Procedure of Cell Therapy (Separation and infusion).- 12. Cell therapy for adult infarction.- 13. Clinical trials on cell therapy for perinatal brain injury: Challenges and opportunities.- 14. A new prospective cell therapy for neonatal brain injury.

About the author










Haruo Shintaku
Department of Pediatrics,
Osaka City University Graduate School of Medicine,
Osaka
Japan

Akira Oka
Department of Pediatrics,
University of Tokyo, 
Tokyo
Japan

Makoto Nabetani, 
Department of Pediatrics,
Yodogawa Christian Hospital, 
Osaka,
Japan


Summary

This book provides a wealth of insights, advances and new perspectives on cell therapy for different types of neonatal ischemic disease, such as Hypoxic-Ischemic Encephalopathy (HIE), Periventricular Leukomalacia (PVL) and neonatal infarction.
These diseases pose serious challenges for neonatologists and neurologists, because the severe sequelae lead to decreasing QOL for patients and their families. Accordingly, new treatments for neonatal ischemic diseases are needed all over the world.
The book develops new effective therapies combined with hypothermia therapy, an established treatment for HIE. After reviewing past approaches, it presents cutting-edge topics in cell therapy, one of the most promising candidates for treating neonatal ischemic disease. Cell Therapy for Neonatal Ischemic Disease will offer readers a better understanding of the current state of the art in this field from bench to bedside, and inspire researchers and physicians to furtherexplore this evolving therapy.

Additional text

“This book reviews advances the evolving cell therapy for various neonatal ischemic diseases. It has 14 chapters, with tables, illustrations and many references. For pediatric neonatologists, hematologists and researchers in biology.” (Pediatric Endocrinology Reviews (PER), Vol. 16 (1), September, 2018)

“The book is aimed mostly at researchers, especially those involved in stem cell therapy. However, neonatologists and pediatric neurologists will find the concepts intriguing and sometimes exciting. The authors seem to be well regarded in this field. … This is a provocative monograph that certainly could inform discussions on this cutting-edge therapy. … For those curious about this novel therapy, this is an interesting read.” (Jay P. Goldsmith, Doody's Book Reviews, May, 2018)

Report

"This book reviews advances the evolving cell therapy for various neonatal ischemic diseases. It has 14 chapters, with tables, illustrations and many references. For pediatric neonatologists, hematologists and researchers in biology." (Pediatric Endocrinology Reviews (PER), Vol. 16 (1), September, 2018)

"The book is aimed mostly at researchers, especially those involved in stem cell therapy. However, neonatologists and pediatric neurologists will find the concepts intriguing and sometimes exciting. The authors seem to be well regarded in this field. ... This is a provocative monograph that certainly could inform discussions on this cutting-edge therapy. ... For those curious about this novel therapy, this is an interesting read." (Jay P. Goldsmith, Doody's Book Reviews, May, 2018)

Product details

Assisted by Makoto Nabetani (Editor), Akir Oka (Editor), Akira Oka (Editor), Haruo Shintaku (Editor)
Publisher Springer, Berlin
 
Languages English
Product format Hardback
Released 01.01.2018
 
EAN 9789811014116
ISBN 978-981-10-1411-6
No. of pages 150
Dimensions 162 mm x 244 mm x 12 mm
Weight 382 g
Illustrations XII, 150 p.
Subjects Natural sciences, medicine, IT, technology > Medicine > Non-clinical medicine

B, Medicine, Neurology, Pediatrics, Neurology & clinical neurophysiology, Obstetrics, Gynaecology & obstetrics, Midwifery, Obstetrics/Perinatology/Midwifery

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.